LIF 247
Alternative Names: LI 247Latest Information Update: 17 Dec 2007
At a glance
- Originator Enhance Lifesciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 19 Nov 2003 Phase-III clinical trials in Depression in USA (unspecified route)